| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |